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EXPRESSION OF TLR2 AND TLR4 IN LESIONS OF PATIENTS WITH TEGUMENTARY AMERICAN 
LEISHMANIASIS
Felipe Francisco TUON(1), Elaine Ribeiro FERNANDES(2), Maria Irma Seixas DUARTE(2) & Valdir Sabbaga AMATO(3)
SUMMARY
Objectives: The aim of this study was to describe the pattern of expression of Toll-like receptor 2 (TLR2) and Toll-like receptor 
4 (TLR4) in skin biopsies of patients with American tegumentary leishmaniasis (ATL) caused by Leishmania braziliensis. Methods: 
This prospective study evaluated 12 patients with ATL caused by Leishmania braziliensis confirmed by polymerase chain reaction. 
Immunohistochemistry was performed to determine the expression of TLR2 and TLR4. The number of NK cells, dendritic cells and 
macrophages in the tissue were calculated. The cytokine expression was determined using the anti-TNF-α, anti-IFN-γ, anti-IL-1 and 
anti-IL-6. Double immunostaining reactions were used to determine the cell expressing TLR2 and TLR4. Results: The numbers 
of cells expressing TLR2 and TLR4 were 145.48 ± 82.46 cell/mm2 and 3.26 ± 4.11 cell/mm2 respectively (p < 0.05). There was no 
correlation of TLR2 and TLR4 with the amount of cytokines and the number of NK cells, dendritic cells or macrophages. The double 
immunostaining revealed that TLR2 was expressed by macrophages. Conclusion: In human cutaneous leishmaniasis caused by 
Leishmania braziliensis, TLR2 is the most common TLR expressed during active disease, mainly by macrophages although without 
correlation with the amount of cytokines and number of cells.
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INTRODUCTION
Tegumentary leishmaniasis continues to be a problem in 
underdeveloped countries and is a continuous worry in developed 
countries due to the possibility of the disease afflicting tourists returning 
from countries where the parasite is endemic16. 
Despite its increasing global incidence, leishmaniasis has become a 
neglected disease with little interest by financial donors, public health 
authorities, and professionals to implement activities to research, prevent, 
or control the disease17.
Several immunological studies have increased our understanding of 
the adaptive response in American tegumentary leishmaniasis (ATL). 
Thus, this disease has been used as a model of Th1 and Th2 responses. 
Unfortunately, there are still several aspects of the initial steps of 
Leishmania spp. infection in humans that are largely unknown.
The Toll-like receptor (TLR) signaling pathway is one of the first 
defensive systems against Leishmania spp.18. After recognition of specific 
antigens, TLRs trigger NF-κB, which then proceeds to the nucleus and 
promotes the transcription and further synthesis of pro-inflammatory 
cytokines3.
Recent studies revealed that TLR2 and TLR4 contribute to the 
recognition of Leishmania major and to the subsequent immune 
response4,8,15. Nevertheless, discrepancy in TLR signaling has been 
observed when in vitro and in vivo studies have been published2,10-13. 
All these previous studies were performed under ideal conditions 
using animal models or cell culture. We studied the expression of 
TLRs in the keratinocytes, but their importance in the dermis, where 
the inflammatory infiltrate occurs, is unknown21. We know that the 
development of new drugs, vaccines, diagnostic tests and prognostic 
perspectives are related to the knowledge of the immune response. 
Considering these facts, it is important to determine the cell of the immune 
response that expresses TLRs as well as the relationship of these receptors 
with other cells and cytokine production. 
The aim of this study was to describe the pattern of expression of 
TLR2 and TLR4 in ATL caused by Leishmania braziliensis. Secondary 
objectives were to determine the cells involved in the expression of TLR 
and to perform a correlation between TLR and cytokine expression.
METHODS
1. Area of study: This prospective study evaluated 100 Brazilian 
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patients with ATL from the Amazon region (Santarem City) from January 
2002 to January 2003. This city is localized at latitude 2°26'6.64"S and 
longitude 54°42'4.04"W. The area of study is 36 m, the climate is hot and 
moist, with a temperature range between 25 ºC and 28 ºC. 
Patients with confirmed diagnosis of ATL were included in the 
study. After informed consent, all patients were submitted to cutaneous 
scraping from the lesion, the Montenegro test, and skin biopsy. Clinical 
diagnosis of ATL was determined as previously described19. We 
included only patients with all the following findings: 1) amastigotes 
present on cutaneous scraping; 2) positive Montenegro’s skin test; 3) 
immunohistochemistry showing Leishmania antigens; 4) Leishmania 
braziliensis confirmed by polymerase chain reaction (PCR). We included 
only skin biopsies with representative material, presence of epidermis 
and dermis, enough area to perform quantitative analysis. A control group 
with normal skin biopsy from patients without cutaneous disease was 
included for statistical analysis. 
This study was approved by the Ethics Board of the School of 
Medicine (CAPPesq da Diretoria Clínica do Hospital das Clínicas e da 
Faculdade de Medicina da Universidade de São Paulo - No. 0913/07). 
2. Laboratory tests: Montenegro’s skin test was performed with 
intradermal injection of leishmanina (L. (L.) amazonensis - OMS MHOM/
BR/73/M2269 - CPPI, Piraquara, PR, Brazil), and the size of the skin 
response was measured after 48 hours. The diameter of induration was 
measured in millimeters. 
Immunohistochemistry for detection of Leishmania antigens 
was performed as described previously using antibodies from 
Leishmania chagasi (a gift from Heitor Andrade Jr. from Instituto de 
Medicina Tropical, Brazil)1. The method is described in the section 
immunohistochemistry below.
3. Polymerase chain reaction for L. (V.) braziliensis: Samples 
from skin biopsies obtained from the borders of the lesions were used 
for PCR. The materials were stored in a buffered solution containing 
150 mM NaCl, 50 mM EDTA, and 100 mM Tris at pH 7.5. DNA was 
obtained from the material following a previously described protocol5. 
Briefly, PCR to identify Leishmania (V.) braziliensis was applied to the 
DNA samples using a sequence of glucose-6-phosphate dehydrogenase. 
The first amplification is performed to detect the presence of DNA from 
subgenera Viannia, using the primers ISVC 5’ (ATC-ACA-ATG-ATG-
GTC-AAC-GCA) and ISVA 5’(GTC-GGT-TAT-CCT-ATT-CGG-GTC). 
About 20 ng of sample DNA was used as a template in the first PCR assay, 
which was performed in a final volume of 50 μL in 1x PCR buffer, 2 mM 
MgCl2, 0.2 mM dNTPs, 0.2 μM of each primer (ISVC 5’ and ISVA 5’), 
and 2 U Taq DNA polymerase. The DNA was denatured at 94 °C for three 
min, followed by 35 cycles of 94 °C for one min, 50 °C for one min, and 
72 °C for one min. A final extension at 72 °C was performed for seven 
min. A 1:100 dilution of this product was then subjected to nested PCR 
using the primers ISVC 5’ (ATC-ACA-ATG-ATG-GTC-AAC-GCA) and 
ISVB 5’ (TAC-TCG-CCA-TGT-CGG-AGG). The PCR products were 
analyzed by agarose gel electrophoresis (2%, TAE buffer).
4. Immunohistochemistry: Cutaneous sections prepared from 
paraffin-embedded biopsies were cut into 5 μm sections and mounted on 
glass slides. The slides were deparaffinized and incubated for 30 min with 
Tris-buffered saline (TBS), Tween20 w/v (Sigma, St Louis, USA), bovine 
serum albumin (BSA) 0.1% (Sigma, St Louis, USA). They were then 
incubated for 30 min with the rabbit anti-TLR2 (AMS Biotechnology, 
Abington, UK, cod. AP1502) or the goat anti-TLR4 antibodies (SANTA 
CRUZ, Santa Cruz, USA, cod. SC10741)
One slide was incubated without primary antibody and constituted 
a negative control for TLR2 and TLR4. The specific antigen-antibody 
reaction was detected with a streptavidin-biotin-peroxidase-based system 
according to the manufacturer’s instructions (LSAB®+system-HRP, 
DakoCytomation, Carpenteria, CA, USA).
Cellular phenotype was determined as described above, using the 
following mouse antibodies: anti-CD68 for macrophages (DAKO, 
Glostrup, Denmark, cod. M876), anti-CD57 for NK cells (LABVISION, 
Fremont, USA, cod. MS136P), and anti-CD1a for dendritic cells 
(SEROTEC, Oxford, UK, cod. MCA1657). Positive control with lymph 
nodes was used.
Cytokine expression was determined as described above, using the 
following antibodies: goat anti-TNF-α (R&D, Minneapolis, USA, cod. 
AF20NA), mouse anti-IFN-γ (R&D, Minneapolis, USA, cod. MAB285), 
anti-IL-1 (R&D, Minneapolis, USA, cod. AF215NA) and goat anti-IL-6 
(R&D, Minneapolis, USA, cod. AF206NA) in BSA 1%, over night at 
4 ºC. Positive control with lymph nodes was used.
For double immunostaining reactions, the slides were incubated 
overnight at 4 °C in the presence of anti-CD68 antibody or anti-CD57 or 
anti-CD1a as described above. The reactions were visualized using the 
3,3’-diaminobenzidine (DAB) chromogen as before. After washing with 
phosphate buffered saline (pH 7.4), the slides were incubated overnight 
at 4 °C in the presence of anti-TLR2 or anti-TLR4 antibodies followed 
by incubation with Envision alkaline phosphatase (DakoCytomation, 
Carpinteria, CA, USA) for 30 minutes at 37 °C. The reactions were 
visualized using Liquid Permanent Red (DakoCytomation, Carpinteria, 
CA, USA) and counterstained with Harris hematoxylin.
5. Quantitative analysis: For each specimen, cells were quantified by 
counting the number of immunolabeled cells in nine randomized high-
power fields considering three levels of depth in the dermis. A x10 ocular 
lens was used with a square grid in a x40 objective marking an area field 
of 0.0625 mm2. This method has been used in previous studies7,20,23,24.
6. Statistical analysis: Data were expressed as median with range 
or mean with standard deviation. Statistical analysis was performed by 
Graph Pad Prism version 4.0 for Windows (Graph Pad software, San 
Diego, CA) using the non-parametric Kruskal-Wallis test for larger group 
comparison, with Dunn post for individual groups and Mann-Whitney 
tests for two sample comparisons. Samples were considered different at 
the 95% (p ≤ 0.05) level of significance.
RESULTS
1. Patients selection: From 100 patients, 16 had negative Montenegro 
skin test; 25 cases without amastigotes on cutaneous scraping; 
immunohistochemistry without Leishmania antigens in 19 cases; 10 
patients with other species than Leishmania braziliensis. Eighteen 
biopsies were discharged because insufficient epidermis or material for 
TUON, F.F.; FERNANDES, E.R.; DUARTE, M.I.S. & AMATO, V.S. - Expression of TLR2 and TLR4 in lesions of patients with tegumentary American leishmaniasis. Rev. Inst. Med. Trop. 
Sao Paulo, 54(3): 159-63, 2012. 
161
sections. Considering the inclusion criteria described above, only 12 
cases were eligible for the evaluation of TLRs.
All 12 patients were male with a median age of 22 [16 - 46] years. 
The median duration of disease before biopsy was 90 [30 - 120] days 
and all lesions were localized in the lower limbs. 
2. Immunohistochemistry: The mean number of cells CD68 
(macrophages), CD57 (NK) and CD1a (dendritic cells) was 
576.70±264.99 cell/mm2, 12.45±9.52 cell/mm2 and 24.21±16.09 cell/mm2, 
respectively. Macrophage was the most common cell in the inflammatory 
infiltrate. The number of macrophages was higher than NK cells and 
dendritic cells (p < 0.001). 
The number of cells expressing IL-1, IL-6, TNF-α and IFN-γ are in 
the Figure 1. Among the cytokines studied, IFN-γ was the most common 
expressed, showing 17.67±18.21 cells/mm2 with this cytokine. In the 
second place was IL-6 with 13.30±13.72 cells/mm2, followed by TNF-α 
(8.85±9.93 cells/mm2) and IL-1 (8.44±9.78 cells/mm2).
The number of cells expressing TLR2 and TLR4 in patients with 
ATL was 145.48±82.46 cell/mm2 and 3.26±4.11 cell/mm2 respectively 
(p = 0.0049). The proportion of TLR2/TLR4 positive cells in the tissue 
was 44:1. The expression of TLR2 and TLR4 in the control group was 
37.33 ± 21.88 cell/mm2 and 10.00 ± 2.77 cell/mm2, respectively.
The linear regression did not show association/correlation between 
the number of cells expressing cytokines with TLR2/TLR4. There was not 
linear association/correlation of number of specific cells (macrophages, 
NK cells and dendritic cells) with the number of cells expressing TLR2 
or TLR4.
The double immunostaining showed that the expression of TLR2 
occurred in macrophages (Fig. 2). Dendritic and NK cells did not express 
TLR2. The co-expression of TLR4 and other cellular phenotypes (CD68, 
CD57 and CD1a) was not determined by double immunostaining.
DISCUSSION
By immunohistochemistry, we observed that the expression of TLR2 
was increased compared to normal skin. The expression of TLR2 was 
significantly higher than TLR4 in ATL. Furthermore, the expression of 
TLR4 was lower in ATL compared to normal skin. These data suggest 
that TLR2 can be more important than TLR4 in the immune response 
of patients with ATL. 
After recognition of specific antigens of Leishmania (glycoinositol 
Fig. 1 - Cellular phenotype (left); cytokine expression (middle) and; TLR2 and TLR4 expression (right) of patients with cutaneous leishmaniasis caused by L. braziliensis. * p < 0.05 macrophages 
vs. other cells and TLRs expression. In the right graph, TLR2 and TLR4 expression is compared with a control group.
Fig. 2 - Immunohistochemistry pattern of TLR2 and TLR4 with other cellular phenotype 
(macrophage-cd68, KN cell - CD57 and dendritic cell - CD1a). In the final right square is 
the double immunohistochemistry showing macrophage expression of TLR2 (A and B), C 
represents a macrophage without TLR2 expression.
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phospholipids and lipophosphoglycans), TLR2 and TLR4 trigger NF-κB, 
which, then, proceeds to the nucleus and promotes the transcription and 
further synthesis of proinflammatory cytokines. 
All TLRs are expressed in macrophages in models of leishmaniasis 
after stimuli with IFN-γ8, however, mRNA transcription of TLR2 is 
increased in the leishmaniasis when compared with other TLRs. Dendritic 
cells, macrophages and NK cells can express TLR2, as demonstrated in 
models of cutaneous leishmaniasis. In our study, TLR2 was expressed 
only by macrophage in the double immunostaining. Macrophage is the 
most important cell in the cutaneous leishmaniasis and several studies 
demonstrated that TLR2 is expressed at the surface of this cell6,8,12,13. 
The absence of TLR2 in other cells can be associated with the phase 
of the disease, because DC and NK cells decrease in this period of the 
leishmaniasis. The cytokines promotes an up-regulation of the TLR2 to 
maintain a continuous inflammatory response by unknown mechanism9. 
Our results are similar to those obtained in experimental models of L. 
major in mice4,6,8. Lipophosphoglycan, a polymer of repeating Galβ1–
4Manα-PO4 units and a prominent Leishmania surface glycoconjugate14, 
activates both mouse macrophages and human NK cells through TLR24,6. 
The binding of lipophosphoglycan to TLR2 enhances IFN-γ and TNF-α 
production and nuclear translocation of NF-κB18. Cytokines expression 
was increased in our study, mainly IFN-γ and IL-6. However, we cannot 
correlate the TLR2 expression with any cytokine evaluated.
During first studies, TLR4 was a promising signaling receptor for 
Leishmania12. Nevertheless, further studies showed that TLR4 was less 
important than TLR2 and cytokine expression was independent of this 
receptor2. KAVOOSI et al. demonstrated in two studies that TLR4 is not 
activated by Leishmania10,11. The importance of TLR4 could be related 
with an alternative activation through the neutrophil elastase in the first 
steps of cutaneous leishmaniasis15. Other TLRs have been associated with 
Leishmania infection. TLR9 is associated with the granuloma formation, 
which is expressed by macrophages22.
Our study was the first to report the immune response related with 
TLR2 and TLR4 with L. braziliensis. The clinical presentation of 
cutaneous leishmaniasis is related with Leishmania species. L. major 
is not found in America, but the immune response is similar to L. 
braziliensis. These data cannot be applied to L. amazonensis, whose 
immune response is predominantly Th219. 
Our data provide additional support for the role of TLR2 in ATL. 
The in situ evaluation of TLR2 and TLR4 expression in the human ATL 
caused by L. braziliensis confirmed data from experimental studies with 
L. major. In a previous review about TLR and leishmaniasis we had 
compromised ourselves to show the in situ immune response of TLR in 
humans, to confirm data from in vitro studies18.
Our knowledge of the innate immune response improved rapidly over 
the last decade, and this has brought new therapeutic prospects to light, 
including the use of TLRs for immunotherapy or vaccine. We showed that 
the immune response and receptor expression of experimental models 
can be similar with that from human. 
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RESUMO
Expressão de TLR2 e TLR4 em lesões de pacientes com 
leishmaniose tegumentar americana
Objetivos: O objetivo deste estudo foi descrever o padrão de 
expressão dos receptores toll-like 2 e 4 (TLR2 e TLR4) em biópsias 
de pele de pacientes com leishmaniose tegumentar americana (LTA). 
Métodos: Este estudo prospectivo avaliou 12 pacientes com LTA 
causada por Leishmania braziliensis confirmada por reação em cadeia 
da polimerase. Imunohistoquímica foi realizada para determinar a 
expressão de TLR2 e TLR4. O número de células NK, células dendríticas 
e macrófagos foi calculado no tecido. A expressão de citocinas foi 
determinada usando anti-TNF-α, anti-IFN-γ, anti-IL-1 e anti-IL-6. Dupla 
marcação foi usada para determinar a célula responsável pela expressão 
de TLR2 e TLR4. Resultados: O número de células expressando TLR2 e 
TLR4 foi 145.48±82.46 cell/mm2 e 3.26 ± 4.11 cell/mm2 respectivamente 
(p < 0.05). Não houve correlação entre a quantidade de expressão de 
TLR2 e TLR4 com a quantidade de citocinas e o número de células 
NK, macrófagos e células dendríticas. A dupla marcação revelou que 
o TLR2 é expresso por macrófagos. Conclusão: Na LTA causada por 
Leishmania braziliensis, TLR2 é o TLR mais comum na doença ativa, 
principalmente por macrófagos sem correlação com a quantidade de 
citocinas e outras células. 
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